| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |